Renasant Bio Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
34
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$263K
- Investors
-
5
Renasant Bio General Information
Description
Operator of a biopharmaceutical research platform intended to develop oral small-molecule therapies for genetic kidney disorders. The company's platform advances corrector and potentiator programs that target the underlying biology of autosomal dominant polycystic kidney disease, enabling nephrologists, healthcare providers, and patients to access disease-modifying treatment options.
Contact Information
Website
www.renasantbio.comCorporate Office
- 2630 Bancroft Way
- Suite 507
- Berkeley, CA 94704
- United States
Corporate Office
- 2630 Bancroft Way
- Suite 507
- Berkeley, CA 94704
- United States
Renasant Bio Timeline
Renasant Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Grant | 01-Jul-2025 | $263K | Completed | Generating Revenue | ||
| 1. Seed Round | 03-Jun-2025 | Completed | Generating Revenue |
Renasant Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-2 | ||||||||
| Seed |
Renasant Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Renasant Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Renasant Bio Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Yale School of Medicine | Corporation | |||
| 5AM Ventures | Venture Capital | Minority | ||
| Atlas Venture | Venture Capital | Minority | ||
| OrbiMed | Growth/Expansion | Minority | ||
| Qiming Venture Partners USA | Venture Capital | Minority |
Renasant Bio FAQs
-
When was Renasant Bio founded?
Renasant Bio was founded in 2022.
-
Where is Renasant Bio headquartered?
Renasant Bio is headquartered in Berkeley, CA.
-
What is the size of Renasant Bio?
Renasant Bio has 34 total employees.
-
What industry is Renasant Bio in?
Renasant Bio’s primary industry is Drug Discovery.
-
Is Renasant Bio a private or public company?
Renasant Bio is a Private company.
-
What is Renasant Bio’s current revenue?
The current revenue for Renasant Bio is .
-
How much funding has Renasant Bio raised over time?
Renasant Bio has raised $55.5M.
-
Who are Renasant Bio’s investors?
Yale School of Medicine, 5AM Ventures, Atlas Venture, OrbiMed, and Qiming Venture Partners USA have invested in Renasant Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
